Molecular Insight Pharmaceuticals Inc. Harvard Case Solution & Analysis

Molecular Insight has developed a new biopharmaceutical to detect heart attacks. Company's unique approach to the protection of intellectual property uses Hatch Waxman Act and orphan drugs. The company is trying to raise $ 7 million in funding for Series B. Whether it should continue its current strategy or change your approach? Includes color exhibits.
To enhance their effectiveness, color cases should be printed in color. "Hide
by Richard G. Hamermesh Source: Harvard Business School 23 pages. Publication Date: January 12, 2005. Prod. #: 805067-PDF-ENG

Molecular Insight Pharmaceuticals Inc. Case Solution Other Similar Case Solutions like

Molecular Insight Pharmaceuticals Inc.

Share This